• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

立体定向体部放射治疗复发性不可切除头颈部癌

Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck Cancers.

作者信息

Strom Tobin, Wishka Christian, Caudell Jimmy J

机构信息

Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.

出版信息

Cancer Control. 2016 Jan;23(1):6-11. doi: 10.1177/107327481602300103.

DOI:10.1177/107327481602300103
PMID:27009451
Abstract

BACKGROUND

Treatment of locoregional, recurrent head and neck cancers following definitive radiotherapy has evolved during the past 30 years. Brachytherapy as well as protracted courses of systemic therapy and chemoradiotherapy result in 12-month survival rates of 40% to 50% but have high rates of severe toxicity. Given the advancements in radiotherapy targeting and delivery, stereotactic body radiotherapy (SBRT) has been investigated as an alternative treatment option with the potential advantages of reduced treatment time and rates of toxicity.

METHODS

The authors reviewed prospective trials and retrospective reports from the past decade addressing the management of locoregional, recurrent, previously radiated head and neck cancers, focusing on SBRT.

RESULTS

The body of evidence is growing in support of reirradiation using SBRT for the treatment of recurrent head and neck cancers. The 1-year survival rates associated with SBRT are promising and similar to those seen with chemotherapy alone and concurrent, conventionally fractionated radiotherapy and chemotherapy. Treatment-related adverse events of reirradiation using SBRT are also similar to other palliative therapies. Late carotid rupture is a relatively rare but concerning late toxicity associated with reirradiation using SBRT.

CONCLUSIONS

SBRT is a promising treatment for locoregional recurrent head and neck cancers. It also offers a logistical advantage over other palliative treatments, as it only requires 1 to 2 weeks of treatment.

摘要

背景

在过去30年中,根治性放疗后局部区域复发性头颈癌的治疗方法不断发展。近距离放疗以及长期的全身治疗和放化疗可使12个月生存率达到40%至50%,但严重毒性发生率较高。鉴于放射治疗靶向和递送技术的进步,立体定向体部放疗(SBRT)已作为一种替代治疗选择进行研究,它具有减少治疗时间和毒性发生率的潜在优势。

方法

作者回顾了过去十年中关于局部区域复发性、曾接受过放疗的头颈癌治疗的前瞻性试验和回顾性报告,重点关注SBRT。

结果

支持使用SBRT对复发性头颈癌进行再放疗的证据越来越多。与SBRT相关的1年生存率很有前景,与单纯化疗以及同期常规分割放疗和化疗的生存率相似。使用SBRT进行再放疗的治疗相关不良事件也与其他姑息治疗相似。晚期颈动脉破裂是与使用SBRT进行再放疗相关的一种相对罕见但令人担忧的晚期毒性反应。

结论

SBRT是治疗局部区域复发性头颈癌的一种有前景的治疗方法。与其他姑息治疗相比,它还具有后勤保障方面的优势,因为它仅需1至2周的治疗时间。

相似文献

1
Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck Cancers.立体定向体部放射治疗复发性不可切除头颈部癌
Cancer Control. 2016 Jan;23(1):6-11. doi: 10.1177/107327481602300103.
2
Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.在先前接受过放疗的头颈癌挽救性手术后辅助立体定向体部放疗±西妥昔单抗。
Laryngoscope. 2014 Jul;124(7):1579-84. doi: 10.1002/lary.24441. Epub 2014 Apr 22.
3
A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck.一项关于立体定向体部放射治疗联合西妥昔单抗对先前接受过放疗的头颈部复发性鳞状细胞癌患者进行再照射的前瞻性2期试验。
Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):480-8. doi: 10.1016/j.ijrobp.2014.11.023. Epub 2015 Jan 30.
4
Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.头颈部癌超分割立体定向体部再照射的安全性和有效性:大型系列的长期随访
Head Neck. 2015 Oct;37(10):1403-9. doi: 10.1002/hed.23763. Epub 2014 Sep 25.
5
Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study.挽救性立体定向再放疗联合或不联合西妥昔单抗治疗局部复发性头颈部肿瘤:一项可行性研究。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):203-9. doi: 10.1016/j.ijrobp.2011.11.054. Epub 2012 Feb 11.
6
Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer.分次立体定向放射外科治疗头颈部癌症的再照射。
Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1411-9. doi: 10.1016/j.ijrobp.2009.06.070. Epub 2010 Jan 7.
7
The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence.立体定向体放射治疗在头颈部癌症复发再照射中的作用。
Crit Rev Oncol Hematol. 2018 Feb;122:194-201. doi: 10.1016/j.critrevonc.2017.12.007. Epub 2017 Dec 15.
8
Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study.同步西妥昔单抗与立体定向体部放疗治疗头颈部复发鳞癌:单机构匹配病例对照研究。
Am J Clin Oncol. 2011 Apr;34(2):165-72. doi: 10.1097/COC.0b013e3181dbb73e.
9
Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors.立体定向体部放疗(SBRT)治疗头颈部原发和复发性肿瘤。
Oral Oncol. 2013 May;49(5):401-6. doi: 10.1016/j.oraloncology.2012.12.009. Epub 2013 Jan 16.
10
Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.立体定向体部放射治疗对头颈部原发性、复发性和转移性肿瘤的应用
Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1047-53. doi: 10.1016/j.ijrobp.2008.09.022. Epub 2009 Mar 26.

引用本文的文献

1
Case Report: Complete response to four cycles of camrelizumab in a PD-L1 negative patient with advanced oral squamous cancer.病例报告:一名晚期口腔鳞癌的程序性死亡配体1(PD-L1)阴性患者对四个周期的卡瑞利珠单抗治疗完全缓解。
Front Immunol. 2025 Feb 24;16:1476455. doi: 10.3389/fimmu.2025.1476455. eCollection 2025.
2
Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.基于磁共振线性加速器组合的立体定向磁共振引导自适应与非自适应放射治疗:当前实践与未来方向。
Cancers (Basel). 2023 Mar 30;15(7):2081. doi: 10.3390/cancers15072081.
3
Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review.
利用放疗克服头颈部癌对免疫疗法的耐药性:综述
Front Oncol. 2021 Jul 1;11:592319. doi: 10.3389/fonc.2021.592319. eCollection 2021.
4
Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.立体定向体部消融放疗用于头颈部小体积肿瘤再放疗与延长生存期相关:大型、单机构、现代队列研究。
Head Neck. 2021 Nov;43(11):3331-3344. doi: 10.1002/hed.26820. Epub 2021 Jul 16.
5
Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma.立体定向体部放射治疗对晚期食管癌先前放化疗后局部区域复发的安全性和有效性
Front Oncol. 2020 Jul 31;10:1311. doi: 10.3389/fonc.2020.01311. eCollection 2020.
6
Salvage Stereotactic Body Radiation Therapy for Locally Recurrent Previously Irradiated Head and Neck Squamous Cell Carcinoma: An Analysis from the RSSearch® Registry.挽救性立体定向体部放射治疗局部复发性既往接受过放疗的头颈部鳞状细胞癌:来自RSSearch®注册研究的分析
Cureus. 2018 Aug 31;10(8):e3237. doi: 10.7759/cureus.3237.
7
Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer.立体定向体部放射治疗复发性、既往接受过放疗的头颈癌
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818780086. doi: 10.1177/1533033818780086.
8
Percutaneous Image-Guided Cryoablation of Head and Neck Tumors for Local Control, Preservation of Functional Status, and Pain Relief.经皮影像引导下对头颈部肿瘤进行冷冻消融以实现局部控制、保留功能状态并缓解疼痛。
AJR Am J Roentgenol. 2017 Feb;208(2):453-458. doi: 10.2214/AJR.16.16446. Epub 2016 Nov 15.
9
Prospective randomized clinical studies involving reirradiation : Lessons learned.涉及再程放疗的前瞻性随机临床研究:经验教训
Strahlenther Onkol. 2016 Oct;192(10):679-86. doi: 10.1007/s00066-016-1024-6. Epub 2016 Aug 17.